TITLE

Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease

AUTHOR(S)
Hawkins, P.; Johnson, L. C.; Nikoletou, D.; Hamnegård, C.-H.; Sherwood, R.; Polkey, M. I.; Moxham, J.
PUB. DATE
October 2002
SOURCE
Thorax;Oct2002, Vol. 57 Issue 10, p853
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The effects of providing ventilatory assistance to patients with severe chronic obstructive pulmonary disease (COPD) during a high intensity outpatient cycle exercise programme were examined. Methods: Nineteen patients (17 men) with severe COPD (mean (SD) forced expiratory volume in 1 second (FEV1) 27 (7)% predicted) underwent a 6 week supervised outpatient cycle exercise programme. Ten patients were randomised to exercise with ventilatory assistance using proportional assist ventilation (PAV) and nine (two women) to exercise unaided. Before and after training patients performed a maximal symptom limited incremental cycle test to determine peak work rate (Wpeak) followed by a constant work rate (CWR) test at 70% of Wpeak achieved in the baseline incremental test. Minute ventilation (VE), heart rate, and arterialised venous plasma lactate concentration [La+] were measured before and after each test. Results: Mean training intensity (Wt/Wpeak) at 6 weeks was 15.2% (95% Cl 3.2 to 27.1) higher in the group that used ventilatory assistance (p=0.016). Peak work rate after training was 1 8.4% (95% Cl 6.4 to 30.5) higher (p=0.005) in the assisted group (p=0.09). [La+] at an identical workload after training was reduced by 30% (95% Cl 16 to 44) in the assisted group (p=0.002 compared with base- line) and by 11% (95% Cl -7 to 31) (p=0.08 compared with baseline) in the unassisted group (mean difference 18.4% (95% Cl 3.3 to 40), p=0.09). A significant inverse relationship was found between reduction in plasma lactate concentration (ΔL) at an equivalent workload after training during the CWR test and Wt/Wpeak achieved during the last week of training (r=-0.7, p=0.0006). Conclusions: PAV enables a higher intensity of training in patients with severe COPD, leading to greater improvements in maximum exercise capacity with evidence of true physiological adaptation.
ACCESSION #
16181807

 

Related Articles

  • Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Donaldson, G. C.; Seemungal, T. A. R.; Bhowmik, A.; Wedzicha, J. A. // Thorax;Oct2002, Vol. 57 Issue 10, p847 

    Background: Chronic obstructive pulmonary disease (COPD) is characterised by both an accelerated decline in lung function and periods of acute deterioration in symptoms termed exacerbations. The aim of this study was to investigate whether these are related. Methods: Over 4 years, peak...

  • Early tiotropium slows lung decline.  // Pulse;9/2/2009, Vol. 69 Issue 27, p11 

    The article reports on the effectiveness of tiotropium used for treating chronic obstructive pulmonary disease (COPD) in patients with early symptoms in slowing decline in lung function. A trial showed that patients with mild disease who had been excluded from previous trials responded to...

  • Spirometry plea in COPD.  // Pulse;9/2/2009, Vol. 69 Issue 27, p11 

    The article reports that using spirometry to identify people at risk of chronic obstructive pulmonary disease (COPD) can help pick up the illness more quickly, delay decline in lung function and reduce symptom burden. The study was led by professor David Price. According to Price, the use of...

  • Review: corticosteroids pIus LABAs reduce exacerbations and mortality more than steroids aIone in COPD. Nannini, L. J. // Evidence Based Medicine;Jun2008, Vol. 13 Issue 3, p74 

    QUESTIONS In patients with stable chronic obstructive pulmonary disease (COPD), how do inhaled corticosteioids (ICSs) combined with long-acting β-agonists (LABAs) compare with ICSs alone? REVIEW SCOPE: Studies selected had ⩾2 weeks' duration and compared combination therapy of ICSs plus...

  • Tiotropium improves lung function and reduces COPD exacerbations. Mayor, Susan // British Journal of Hospital Medicine (17508460);Nov2008, Vol. 69 Issue 11, p614 

    The article reports on the study from Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT). After 4-year global trial in chronic obstructive pulmonary disease (COPD), UPLIFT is evaluating the potential of the drug to slow disease progression by reducing the rate of...

  • Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Mannino, David M.; Diaz-Guzman, Enrique; Buist, Sonia // Respiratory Research;Oct2011, Vol. 12 Issue 10, p1 

    Background: Chronic obstructive pulmonary disease (COPD) is supposed to be classified on the basis of postbronchodilator lung function. Most longitudinal studies of COPD, though, do not have post-bronchodilator lung function available. We used pre-and post bronchodilator lung function data from...

  • Combination therapy slows progression of COPD.  // Pulse;8/27/2008, Vol. 68 Issue 28, p8 

    The article cites a study which found out that long-acting ß-agonists combined with an inhaled steroid slow the progression of lung disease in patients with chronic obstructive pulmonary disease (COPD) in Great Britain. It examined that patients treated with salmeterol and fluticasone had...

  • Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea. Kyungsoo Chung; Kyungjoo Kim; Jiye Jung; Kyungwon Oh; Yeonmok Oh; Sekyu Kim; Jinhee Kim; Youngsam Kim // BMC Pulmonary Medicine;2014, Vol. 14 Issue 1, p1 

    Background We investigated patients with chronic obstructive pulmonary disease (COPD) to analyze patterns and identify determinants of healthcare use, according to the severity of airflow obstruction. We used retrospective cohort data from a combination of the 4th Korea National Health and...

  • The importance of primary care spirometry. Scullion, Jane; Holmes, Steve // Independent Nurse;2/15/2010, p33 

    The article focuses on the use and interpretation of spirometry, which was first used in 1809 and is defined as a measurement of breathing. Spirometry is vital in the diagnosis and management of chronic obstructive pulmonary disease, asthma and other respiratory disease. There are several types...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics